Core Insights - The 2025 China Biomaterials Conference was held in Shaoxing, Zhejiang, featuring prominent experts from China and abroad discussing the frontiers and applications of biomaterials [1] - Phoenix Regenerative Technology Development (Chengdu) Co., Ltd. showcased its self-developed triple-helix biomimetic collagen research results, attracting significant attention from attendees [1] Group 1: Research and Development - A presentation titled "Safety and Efficacy Evaluation of Chemically Synthesized Triple-Helix Biomimetic Collagen and Latest Research Progress" was delivered by Qin Xingjiong, founder of Phoenix Regenerative Technology, highlighting collaborative research with several prestigious institutions [3] - The research, published in the SCI Q1 journal "Frontiers in Bioengineering and Biotechnology," confirmed the safety, structural stability, and excellent thermal stability of the biomimetic collagen, demonstrating its potential for regenerative biomedical applications [3] Group 2: Technological Advancements - The foundational research for this technology began in 2001 under Professor Masao Yawahara at Kyoto University, evolving through collaboration with multiple universities and receiving national support in Japan [4] - The technology has undergone significant upgrades from version 1.1 to 2.0, resulting in multiple invention patents and ongoing applications for PCT international patents [4] Group 3: Product Development and Market Potential - The product features a stable triple-helix structure and collagen fiber bundles, addressing key scientific challenges in collagen protein preparation and demonstrating cost advantages in the synthesis process [6] - The biomimetic collagen has completed registration with the National Medical Products Administration and is set to launch products for various applications, including functional cosmetics, medical dressings, and tissue engineering [6] Group 4: Competitive Edge - The technology has been confirmed as globally pioneering and internationally leading, with the 2.0 version enhancing stability and self-assembly characteristics through innovative processes [7] - The use of 300 kV cryo-transmission electron microscopy to capture the ultra-microstructure of collagen fiber bundles has validated the reproducibility and consistency of the product across multiple batches [7]